These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Linear B Cell Epitopes Derived from the Multifunctional Surface Lipoprotein BBK32 as Targets for the Serodiagnosis of Lyme Disease. Toumanios C; Prisco L; Dattwyler RJ; Arnaboldi PM mSphere; 2019 May; 4(3):. PubMed ID: 31043513 [TBL] [Abstract][Full Text] [Related]
3. Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease. Signorino G; Arnaboldi PM; Petzke MM; Dattwyler RJ Clin Vaccine Immunol; 2014 May; 21(5):704-11. PubMed ID: 24623628 [TBL] [Abstract][Full Text] [Related]
4. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. Liang FT; Steere AC; Marques AR; Johnson BJ; Miller JN; Philipp MT J Clin Microbiol; 1999 Dec; 37(12):3990-6. PubMed ID: 10565920 [TBL] [Abstract][Full Text] [Related]
5. Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease. Arnaboldi PM; Seedarnee R; Sambir M; Callister SM; Imparato JA; Dattwyler RJ Clin Vaccine Immunol; 2013 Apr; 20(4):474-81. PubMed ID: 23365204 [TBL] [Abstract][Full Text] [Related]
6. Use of Peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera. Hamby CV; Llibre M; Utpat S; Wormser GP Clin Diagn Lab Immunol; 2005 Jul; 12(7):801-7. PubMed ID: 16002626 [TBL] [Abstract][Full Text] [Related]
7. Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease. Burbelo PD; Issa AT; Ching KH; Cohen JI; Iadarola MJ; Marques A Clin Vaccine Immunol; 2010 Jun; 17(6):904-9. PubMed ID: 20392886 [TBL] [Abstract][Full Text] [Related]
8. Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America. Arnaboldi PM; Sambir M; Dattwyler RJ Clin Vaccine Immunol; 2014 Oct; 21(10):1426-36. PubMed ID: 25121778 [TBL] [Abstract][Full Text] [Related]
9. Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease. Jacek E; Tang KS; Komorowski L; Ajamian M; Probst C; Stevenson B; Wormser GP; Marques AR; Alaedini A J Immunol; 2016 Feb; 196(3):1036-43. PubMed ID: 26718339 [TBL] [Abstract][Full Text] [Related]
10. Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes. Batool M; Caoili SEC; Dangott LJ; Gerasimov E; Ionov Y; Piontkivska H; Zelikovsky A; Waghela SD; Rogovskyy AS Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866906 [TBL] [Abstract][Full Text] [Related]
12. BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease. Coleman AS; Rossmann E; Yang X; Song H; Lamichhane CM; Iyer R; Schwartz I; Pal U Clin Vaccine Immunol; 2011 Mar; 18(3):406-13. PubMed ID: 21177911 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vivo expressed Borrelia burgdorferi antigens for improved IgM serodiagnosis of early Lyme disease. Brandt KS; Ullmann AJ; Molins CR; Horiuchi K; Biggerstaff BJ; Gilmore RD Diagn Microbiol Infect Dis; 2019 Mar; 93(3):196-202. PubMed ID: 30344068 [TBL] [Abstract][Full Text] [Related]
14. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. Bacon RM; Biggerstaff BJ; Schriefer ME; Gilmore RD; Philipp MT; Steere AC; Wormser GP; Marques AR; Johnson BJ J Infect Dis; 2003 Apr; 187(8):1187-99. PubMed ID: 12695997 [TBL] [Abstract][Full Text] [Related]
15. Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease. Lahey LJ; Panas MW; Mao R; Delanoy M; Flanagan JJ; Binder SR; Rebman AW; Montoya JG; Soloski MJ; Steere AC; Dattwyler RJ; Arnaboldi PM; Aucott JN; Robinson WH J Clin Microbiol; 2015 Dec; 53(12):3834-41. PubMed ID: 26447113 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease. Ledue TB; Collins MF; Young J; Schriefer ME Clin Vaccine Immunol; 2008 Dec; 15(12):1796-804. PubMed ID: 18945880 [TBL] [Abstract][Full Text] [Related]
17. The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis. Peltomaa M; McHugh G; Steere AC Otol Neurotol; 2004 Sep; 25(5):838-41. PubMed ID: 15354020 [TBL] [Abstract][Full Text] [Related]
19. Persistent Anti- Markowicz M; Reiter M; Gamper J; Stanek G; Stockinger H Microbiol Spectr; 2021 Dec; 9(3):e0102021. PubMed ID: 34937165 [TBL] [Abstract][Full Text] [Related]
20. A biochip-based combined immunoassay for detection of serological status of Borrelia burgdorferi in Lyme borreliosis. Huang NL; Ye L; Lv H; Du YX; Schneider M; Fan LB; Du WD Clin Chim Acta; 2017 Sep; 472():13-19. PubMed ID: 28676442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]